Prange Karen
Director at ATRC; Director at ViewRay, Inc.; SVP&Pres, Uro & Pelvic Health at BSX
- Sold, on record
- $1.5M
- Dollars the filings state
- Form 4 sales
- 11
- Latest Aug 5, 2026
- Form 144 notices
- 4
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- ATRCAtriCure, Inc.Director
- ViewRay, Inc.Director
- BSXBOSTON SCIENTIFIC CORPSVP&Pres, Uro & Pelvic Health
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- ViewRay, Inc.129,466 shares
- BSX61,971 shares
- ATRC13,377 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ATRCNo planJun 8, 2023 2023
Sold 713 shares at $47.89 ($34k)
Prange Karen, Director
No 10b5-1 planSold 4.2% of holdings ($807k position)16,140 shares leftFirst sale on recordFollows a Form 144Filing
- 2 Form 144 notice ViewRay, Inc.NoticeJul 19, 2023 +41 days
Filed to sell 91,866 shares ($7k)
Prange Karen, Director
No 10b5-1 planFirst sale on recordFiling
- 3 Form 144 notice ViewRay, Inc.NoticeJul 21, 2023 +2 days
Filed to sell 37,600 shares ($2k)
Prange Karen, Director
No 10b5-1 planFirst sale on recordFiling
- 4 Form 4 sale ViewRay, Inc.UnusualJul 21, 2023 same day
Sold 129,466 shares at $0.0713 ($9k)
Prange Karen, Director
No 10b5-1 planSold 93.6% of holdings ($10k position)8,799 shares leftFirst sale on recordFollows a Form 144Filing
- 5 Form 144 notice ATRCNoticeMar 5, 2025 +593 days
Filed to sell 6,100 shares ($232k)
Prange Karen, Director
No 10b5-1 planFiling
- 6 Form 4 sale ATRCUnusualMar 5, 2025 same day
Sold 6,100 shares at $38.12 ($233k)
Prange Karen, Director
No 10b5-1 planSold 25.5% of holdings ($912k position)17,828 shares leftFollows a Form 144Filing
- 7 Form 4 sale ATRCNo planMay 20, 2026 +441 days
Sold 3,000 shares at $28.65 ($86k)
Prange Karen, Director
No 10b5-1 planSold 10.2% of holdings ($842k position)26,373 shares leftFiling
- 8 Form 4 sale ATRCNo planAug 5, 2026 +77 days
Sold 3,564 shares at $38.80 ($138k)
Prange Karen, Director
No 10b5-1 planSold 13.5% of holdings ($1M position)22,809 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (15)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Aug 7, 2026 | ATRC | Director | Form 4 sale | 3,564 | $138k | 13.5% | No plan | SEC |
| May 20, 2026 | May 22, 2026 | ATRC | Director | Form 4 sale | 3,000 | $86k | 10.2% | No plan | SEC |
| Mar 5, 2025 | Mar 7, 2025 | ATRC | Director | Form 4 sale | 6,100 | $233k | 25.5% | Unusual | SEC |
| Mar 5, 2025 | Mar 5, 2025 | ATRC | Director | Form 144 notice | 6,100 | $232k | Notice | SEC | |
| Jul 21, 2023 | Jul 21, 2023 | ViewRay, Inc. | Director | Form 4 sale | 129,466 | $9k | 93.6% | Unusual | SEC |
| Jul 21, 2023 | Jul 21, 2023 | ViewRay, Inc. | Director | Form 144 notice | 37,600 | $2k | Notice | SEC | |
| Jul 19, 2023 | Jul 19, 2023 | ViewRay, Inc. | Director | Form 144 notice | 91,866 | $7k | Notice | SEC | |
| Jun 8, 2023 | Jun 12, 2023 | ATRC | Director | Form 4 sale | 713 | $34k | 4.2% | No plan | SEC |
| Jun 8, 2023 | Jun 8, 2023 | ATRC | Director | Form 144 notice | 713 | $34k | Notice | SEC | |
| Mar 8, 2016 | Mar 8, 2016 | BSX | SVP&Pres, Uro & Pelvic Health | Form 4 sale | 14,747 | $255k | 27.8% | Unusual | SEC |
| Feb 8, 2016 | Feb 9, 2016 | BSX | SVP&Pres, Uro & Pelvic Health | Form 4 sale | 6,216 | $100k | 20.8% | Plan not stated | SEC |
| Jul 7, 2015 | Jul 7, 2015 | BSX | SVP&Pres, Uro & Women's Health | Form 4 sale | 17,456 | $308k | 50.0% | Unusual | SEC |
| Mar 3, 2015 | Mar 4, 2015 | BSX | SVP&Pres, Uro & Women's Health | Form 4 sale | 2,492 | $42k | 12.5% | Plan not stated | SEC |
| Feb 27, 2015 | Mar 2, 2015 | BSX | SVP&Pres, Uro & Women's Health | Form 4 sale | 1,307 | $22k | 7.0% | Plan not stated | SEC |
| Dec 10, 2014 | Dec 10, 2014 | BSX | SVP&Pres, Uro & Women's Health | Form 4 sale | 19,753 | $250k | 53.1% | Unusual | SEC |